¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"fermentation Lactobacillus casei factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
protein synthesis factor
´Ü¹éÇÕ¼ºÀÎÀÚ
psychogenic factor
Á¤½Å¼ºÀÎÀÚ
psychological factor
½É¸®¿äÀÎ
psychosocial factor
½É¸®»çȸ¿äÀÎ
phantom scatter factor
ÆÒÅÒ»ê¶õ°è¼ö
quality factor
1. Áú¿ä¼Ò 2. Á¤¼ºÀÎÀÚ
racial factor
ÀÎÁ¾¿äÀÎ
realization factor
½ÇÇöÀÎÀÚ
recruitment factor
µ¿¿øÀÎÀÚ
reducing factor
ȯ¿øÀÎÀÚ
reinforcing factor
°È¿äÀÎ
relaxing factor
ÀÌ¿ÏÀÎÀÚ
radiation weighting factor
¹æ»ç¼±°¡Áß°è¼ö
resistance factor
³»¼ºÀÎÀÚ, ÀúÇ×ÀÎÀÚ
resistance transfer factor
³»¼ºÀü´ÞÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
risk factor
À§ÇèÀÎÀÚ
roentgen-to-rad conversion factor
·ÛÆ®°Õ¶óµåº¯È¯°è¼ö
safety factor
¾ÈÀü°è¼ö
scatter factor
»ê¶õ°è¼ö
sebotropic factor
Áö·çÃËÁøÀÎÀÚ
skin vascular permeability factor
ÇǺÎÇ÷°üÅõ°úÀÎÀÚ
somatotropin release inhibiting factor
¼ºÀåÈ£¸£¸óÀ¯¸®¾ïÁ¦ÀÎÀÚ
spreading factor
È®»êÀÎÀÚ
stable factor
¾ÈÁ¤ÀÎÀÚ
stroma factor
¹öÆÀÁúÀÎÀÚ
sunprotective factor
Àϱ¤º¸È£Áö¼ö
testis-determining factor
°íȯ°áÁ¤ÀÎÀÚ
therapeutic gain factor
Ä¡·áÀ̵æ°è¼ö
thyrotrophin releasing factor
¹æÆÐ»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ, °©»ó»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ
time-dose factor
½Ã°£¼±·®ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
growth factor
¼ºÀåÀÎÀÚ(à÷íþì×í).
growth factor
Áõ½ÄÀÎÀÚ
growth factor
¼ºÀå ÀÎÀÚ(à÷íþ ì×í)
growth factor, B cell (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
growth hormone-releasing factor
¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ<--¹æÃâÀÎÀÚ>
growth promoting factor
¼ºÀåÃËÁøÀÎÀÚ(à÷íþõµòäì×í), ¹ßÀ°ÃËÁø¹°Áú(Û¡ëÀõµòäÚªòõ)
hageman factor
ÇϰԸ¸ ÀÎÀÚ, Hageman ÀÎÀÚ
hematopoietic growth factor
Á¶Ç÷¼ºÀåÀÎÀÚ
hemorrhagic diathesis,clotting factor abnormalities
ÀÀ°íÀÎÀÚ ÀÌ»ó
hepatocyte growth factor
°£¼¼Æ÷¼ºÀåÀÎÀÚ
histamine sensitizing factor =HSF
È÷½ºÅ¸¹Î°¨ÀÛÀÎÀÚ(¡ÊïíÂì×í).
homologous restriction factor
µ¿Á¾Á¦ÇÑÀÎÀÚ
hyperglycemic glycogenolytic factor
°íÇ÷´ç¼º ´ç¿øºÐÇØ(¼º) ÀÎÀÚ.
hypothalamic releasing factor
½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ(ë¤×ãì×í).
hypothalamic releasing factor
½Ã»óÇϺιæÃâÀÎÀÚ.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
dilution factor
¹±ÈûÀÎÀÚ(¡ì×í), Èñ¼®ÀÎÀÚ.
dose conversion factor
¼±·®º¯È¯°è¼ö
dose limiting factor
¼±·®ÇѵµÀÎÀÚ, ¼±·®Á¦ÇÑÀÎÀÚ
dose modifying factor
¼±·®¼ö½Ä°è¼ö
dose-reduction factor
¼±·®°¨¼Ò°è¼ö
drug resistance factor
¾àÁ¦³»¼ºÀÎÀÚ
drug resistance transfer factor
¾àÁ¦³»¼ºÀü´ÞÀÎÀÚ
duplicate factor
Áߺ¹ÀÎÀÚ.
early pregnancy factor(EPF)
ÃʱâÀÓ½ÅÀÎÀÚ
edaphic factor
ÅäÁöÀÎÀÚ(ÊÙËöËö).
elongation factor
¿¬ÀåÀÎÀÚ(¡ì×í).
elongation factor
½ÅÀåÀÎÀÚ
enabling factor
ÀÇ·áÀÌ¿ë °¡´É¿äÀÎ.
encephalitogenic factor
³ú¿°À¯¹ßÀÎÀÚ
encephalitogenic factor
³ú¿°À¯¹ßÀÎÀÚ.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½